Financing ·
Scholar Rock filed a prospectus supplement to offer up to $200 million in additional common stock under its…
SRRKScholar Rock Holding Corp
Scholar Rock filed a prospectus supplement to offer up to $200 million in additional common stock under its at-the-market (ATM) program with Jefferies. This filing replaces and supersedes the prior prospectus supplement dated November 14, 2025, terminating that previous offering. The company has raised approximately $257.7 million in net proceeds from shares sold under the ATM Program to date. Scholar Rock is a biopharmaceutical company focused on discovering and developing therapies for serious diseases.